Skip to content

Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple Sclerosis

Efficacy of Extracorporeal Shock Wave Therapy in Enhancing Plantar Sensitivity and Postural Stability in Multiple Sclerosis: A Quantitative Gait and Sensory Analysis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07514104
Enrollment
54
Registered
2026-04-07
Start date
2021-07-01
Completion date
2025-10-15
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Sensorimotor Gait Disorder

Brief summary

This randomized controlled trial aimed to investigate the efficacy of Extracorporeal Shock Wave Therapy (ESWT) on plantar somatosensory function, knee joint proprioception, and spatiotemporal gait parameters in individuals diagnosed with Multiple Sclerosis (MS). The study included participants with a spasticity level below 1+, with the intervention group receiving ESWT three times per week over a 6-week period. To evaluate sensory changes, light touch thresholds were measured at six plantar sites-the heel, medial longitudinal arch, 1st and 5th metatarsal heads, and the 1st and 5th toes-using the Semmes-Weinstein monofilament kit. Additionally, two-point discrimination was assessed at the heel, and vibration duration was measured at the metatarsal heads using a 128 Hz tuning fork. Proprioception was quantified via the active knee joint reposition test in a closed kinetic chain position, measuring the absolute angular error at a 60° target angle. Postural stability and dynamic gait were objectively analyzed using the Win-Track platform and a reliable 3-step protocol to record parameters such as gait cycle duration, step length, cadence, and maximum plantar pressure. Static balance was further evaluated by recording the percentage of body weight transferred to each foot. By targeting both mechanoreceptor sensitivity and joint position sense, this 6-week ESWT intervention seeks to enhance the overall functional mobility and stability of MS patients.

Interventions

The study group received bilateral Extracorporeal Shock Wave Therapy (ESWT) applied to the plantar surface of both feet. The intervention was administered three times per week for a total duration of 6 weeks. The primary goal of this bilateral application was to modulate sensory thresholds and enhance postural stability by stimulating mechanoreceptors across the entire weight-bearing surface of the feet

Sponsors

Furkan Bilek
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Multiple Sclerosis * Spasticity level below 1+ according to the Modified Ashworth Scale * Ability to walk independently or with assistive devices to perform the 3-step gait protocol * Willingness to participate in a 6-week intervention involving bilateral plantar ESWT * Stable medical condition without a recent relapse within the last 3 months

Exclusion criteria

* Presence of severe cognitive impairment that prevents following test instructions * Other neurological disorders (e.g., Parkinson's disease, polyneuropathy) that could interfere with sensory or gait assessments * Presence of open wounds, active infections, or skin integrity issues on the plantar surface of the feet * Contraindications for Extracorporeal Shock Wave Therapy

Design outcomes

Primary

MeasureTime frameDescription
Static Postural BalanceFrom enrollment to the end of treatment at 6 weeksStatic balance analysis was performed using the Win-Track platform while participants stood barefoot with arms at their sides. The percentage (%) of body weight transferred to each foot was recorded to assess postural stability and symmetry
Plantar Light Touch Sensitivity ThresholdFrom enrollment to the end of treatment at 6 weeksThe Semmes-Weinstein monofilament kit was used to evaluate light touch sensation on the soles of both feet. Eight monofilament levels were applied to the heel, medial longitudinal arch, 1st and 5th metatarsal heads, and the 1st and 5th toes. The average of the thresholds from these six plantar sites was recorded, where higher thresholds indicate lower sensitivity
Gait cycle durationFrom enrollment to the end of treatment at 6 weeksThe Win-Track platform (MEDICAPTEURS Technology, France) was used to measure gait parameters during barefoot walking using a 3-step protocol. Parameters include gait cycle duration (sec). This provides quantitative information about the patient's dynamic gait efficiency.
Step length6 From enrollment to the end of treatment at 6 weeksThe Win-Track platform (MEDICAPTEURS Technology, France) was used to measure gait parameters during barefoot walking using a 3-step protocol. Parameters include step length (cm). This provides quantitative information about the patient's dynamic gait efficiency.
CadenceFrom enrollment to the end of treatment at 6 weeksThe Win-Track platform (MEDICAPTEURS Technology, France) was used to measure gait parameters during barefoot walking using a 3-step protocol. Parameters include cadence (steps/min). This provides quantitative information about the patient's dynamic stability and gait efficiency.
Single-support timeFrom enrollment to the end of treatment at 6 weeksThe Win-Track platform (MEDICAPTEURS Technology, France) was used to measure gait parameters during barefoot walking using a 3-step protocol. Parameters include single-support time(Sec). This provides quantitative information about the patient's dynamic stability and gait efficiency.
Swing phaseFrom enrollment to the end of treatment at 6 weeksThe Win-Track platform (MEDICAPTEURS Technology, France) was used to measure gait parameters during barefoot walking using a 3-step protocol. Parameters include swing phase (Sec). This provides quantitative information about the patient's dynamic stability and gait efficiency.

Secondary

MeasureTime frameDescription
Vibration DurationFrom enrollment to the end of treatment at 6 weeksA 128 Hz tuning fork was used to measure the duration that vibration is perceived on the heads of the 1st and 5th metatarsals. A chronometer measured the time until the participant could no longer feel the vibration.
Knee Position SenseFrom enrollment to the end of treatment at 6 weeksKnee position sense was assessed using the active joint reposition test in a closed kinetic chain position with a Digital Inclinometer. Participants squatted to a target angle of 60° and attempted to reproduce it. The difference between the target angle and the reproduced angle was recorded as the absolute angular error in degrees.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026